BTG Receives “Hold” Rating from FinnCap (BTG)
BTG (LON:BTG)‘s stock had its “hold” rating reiterated by FinnCap in a research note issued on Thursday, American Banking and Market News reports.
A number of other analysts have also recently weighed in on BTG. Analysts at Investec reiterated a “buy” rating on shares of BTG (LON:BTG) in a research note to investors on Wednesday, September 25th. They now have a GBX 472 ($7.62) price target on the stock. Separately, analysts at Shore Capital Stockbrokers reiterated a “buy” rating on shares of BTG (LON:BTG) in a research note to investors on Tuesday, September 17th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of GBX 443.67 ($7.16).
BTG (LON:BTG) traded up 1.29% on Thursday, hitting GBX 385.40. 195,924 shares of the company’s stock traded hands. BTG has a 52-week low of GBX 313.70 and a 52-week high of GBX 402.40. The stock has a 50-day moving average of GBX 383.5 and a 200-day moving average of GBX 366.0.
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.